home Home About Us Newsroom Real Talk: 12% of Americans report using GLP-1 medications In an episode of Real Talk, Denver7's Micah Smith discusses the many questions surrounding the immediate and long-term impacts of these type of drugs with patients, doctors and counselors Return to Newsroom Share on Facebook Share on LinkedIn Share on X November 17, 2025 More than 12% of Americans have used a GLP-1 medications for weight loss, according to a KFF (formerly Kaiser Family Foundation) poll involving about 1,500 respondents
Medications like semaglutide and tirzepatide can persist for days, providing sustained activation of these pathways
Previous research indicates that lifestyle counselling, exercise interventions, antipsychotic substitution, discontinuation and dose reduction may represent potential avenues for treatment, although their efficacy is limited [11,12,13,14,15]
The upstream genetic factor LifeMD does not screen An intake form captures weight, history, and medications, but no telehealth program of this kind screens the genetic architecture underneath your metabolism
Perplexity pulls a majority of its answers from community surfaces
A NAD+ shot is simply a single injection of NAD+ delivered either subcutaneously or intramuscularly